Low Circulating TRAIL Levels Are Associated with Increase of Resistin and Lipocalin-2/ngal Adipokines in Postmenopausal Women
出版年份 2017 全文链接
标题
Low Circulating TRAIL Levels Are Associated with Increase of Resistin and Lipocalin-2/ngal Adipokines in Postmenopausal Women
作者
关键词
-
出版物
MEDIATORS OF INFLAMMATION
Volume 2017, Issue -, Pages 1-8
出版商
Hindawi Limited
发表日期
2017-09-06
DOI
10.1155/2017/5356020
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Glucose intolerance after chronic stress is related with downregulated PPAR-γ in adipose tissue
- (2016) Vitor H. Pereira et al. Cardiovascular Diabetology
- Clinical perspectives of TRAIL: insights into central nervous system disorders
- (2016) Veronica Tisato et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Serum Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Older Subjects with Dementia and Mild Cognitive Impairment
- (2016) Veronica Tisato et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Redox signaling and oxidative stress: Cross talk with TNF-related apoptosis inducing ligand activity
- (2016) Rebecca Voltan et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Oxidative challenge in Alzheimer's disease: state of knowledge and future needs
- (2016) Carlo Cervellati et al. JOURNAL OF INVESTIGATIVE MEDICINE
- TRAIL (TNF-related apoptosis-inducing ligand) inhibits human adipocyte differentiation via caspase-mediated downregulation of adipogenic transcription factors
- (2016) Verena Zoller et al. Cell Death & Disease
- Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease
- (2016) Stella Bernardi et al. Biomed Research International
- Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders
- (2016) Sung Sik Choe et al. Frontiers in Endocrinology
- TRAIL Modulates the Immune System and Protects against the Development of Diabetes
- (2015) Fleur Bossi et al. Journal of Immunology Research
- Inverse Correlation Between Circulating Levels of TNF-Related Apoptosis-Inducing Ligand and 17β-Estradiol
- (2014) Giorgio Zauli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Association of Serum Tumor Necrosis Factor-Related Apoptosis Inducing Ligand with Body Fat Distribution as Assessed by Dual X-Rays Absorptiometry
- (2014) Carlo Cervellati et al. MEDIATORS OF INFLAMMATION
- Tumor necrosis factor-related apoptosis-inducing ligand in vascular inflammation and atherosclerosis: A protector or culprit?
- (2014) Wen Cheng et al. VASCULAR PHARMACOLOGY
- The levels of circulating TRAIL at the onset of type 1 diabetes are markedly decreased in patients with ketoacidosis and with the highest insulin requirement
- (2013) Gianluca Tornese et al. ACTA DIABETOLOGICA
- Mechanism and clinical evidence of lipocalin-2 and adipocyte fatty acid-binding protein linking obesity and atherosclerosis
- (2013) Guangyu Wu et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Association of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) with Central Adiposity and Low-Density Lipoprotein Cholesterol
- (2013) Gloria Brombo et al. PLoS One
- On the TRAIL of obesity and diabetes
- (2013) Hanis H. Harith et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- TRAIL (TNF-related apoptosis-inducing ligand) regulates adipocyte metabolism by caspase-mediated cleavage of PPARgamma
- (2013) M Keuper et al. Cell Death & Disease
- Adipokines Mediate Inflammation and Insulin Resistance
- (2013) Hyokjoon Kwon et al. Frontiers in Endocrinology
- The energy balance positively regulates the levels of circulating TNF-related apoptosis inducing ligand in humans
- (2012) Gianni Biolo et al. CLINICAL NUTRITION
- TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation
- (2012) Stella Bernardi et al. CLINICAL SCIENCE
- Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients
- (2012) A. Bisgin et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- State of Art and Recent Developments of Anti-Cancer Strategies Based on TRAIL
- (2012) Stella Bernardi et al. Recent Patents on Anti-Cancer Drug Discovery
- TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe −/− mice
- (2011) B. A. Di Bartolo et al. DIABETOLOGIA
- 17β-estradiol levels and oxidative balance in a population of pre-, peri-, and post-menopausal women
- (2011) Carlo Cervellati et al. GYNECOLOGICAL ENDOCRINOLOGY
- Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy
- (2011) Yu-Hung Chang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Lipocalin-2 Deficiency Attenuates Insulin Resistance Associated With Aging and Obesity
- (2010) I. K.M. Law et al. DIABETES
- The Role of Adipose Tissue and Adipokines in Obesity-Related Inflammatory Diseases
- (2010) Carmela Rita Balistreri et al. MEDIATORS OF INFLAMMATION
- Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects
- (2010) David T. Ashley et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Prognostic value of apoptosis markers in advanced heart failure patients
- (2009) A. Niessner et al. EUROPEAN HEART JOURNAL
- Body mass index is a major determinant of abdominal fat accumulation in pre-, peri- and post-menopausal women
- (2009) Carlo Cervellati et al. GYNECOLOGICAL ENDOCRINOLOGY
- Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction
- (2009) Paola Secchiero et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search